Literature DB >> 1095613

A comparison of the acute effects of radiation therapy, including or excluding the thymus, on the lymphocyte subpopulations of cancer patients.

J A Stratton, P E Byfield, J E Byfield, R C Small, J Benfield, Y Pilch.   

Abstract

Radiation therapy to either mediastinum or pelvis causes a rapid decrease in circulating lymphocytes of both B and T types and in addition an impairment in the function of the remaining lyphocytes, as measured by their ability to proliferate in response to mitogens. The acute depression is short-lived. Substantial recovery is apparent within 3 wk after cessation of therapy; however, most patients show a modest, chronic depression in both numbers and functional capacities of circulating lymphocytes. T cells are somewhat more sensitive than B cells, but both are affected. Irradiation of the thymus per se seems to have little influence on the acute changes which occur, as patients receiving pelvic and mediastinal (including thymic) radiotherapy show a similiar degree of lymphopenia and depression of lymphocyte responsiveness.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1095613      PMCID: PMC436559          DOI: 10.1172/JCI108084

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Reduction of gamma-globulins.

Authors:  J B FLEISCHMAN; R H PAIN; R R PORTER
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

2.  Purification of human T and B lymphocytes.

Authors:  M F Greaves; G Brown
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

Review 3.  Cytotoxic effects of lymphoid cells in vitro.

Authors:  P Perlmann; G Holm
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

Review 4.  The thymus humoral factor under scrutiny.

Authors:  A J Davies
Journal:  Agents Actions       Date:  1969-11

5.  Immunoglobulin determinants on the surface of mouse lymphoid cells.

Authors:  M C Raff; M Sternberg; R B Taylor
Journal:  Nature       Date:  1970-02-07       Impact factor: 49.962

6.  Tissue localization of two populations of human lymphocytes distinguished by membrane receptors.

Authors:  N P Silveira; N F Mendes; M E Tolnai
Journal:  J Immunol       Date:  1972-05       Impact factor: 5.422

7.  Blood lymphocyte replicating ability as a measurement of radiation dosage.

Authors:  P L Ilbery; A B Rickinson; C E Thrum
Journal:  Br J Radiol       Date:  1971-11       Impact factor: 3.039

8.  Rosette formation, a test for cellular immunity.

Authors:  J Wybran; H H Fudenberg
Journal:  Trans Assoc Am Physicians       Date:  1971

9.  Theta-bearing and complement-receptor lymphocytes are distinct populations of cells.

Authors:  C Bianco; V Nussenzweig
Journal:  Science       Date:  1971-07-09       Impact factor: 47.728

10.  Brain-associated stem cell antigen: an antigen shared by brain and hemopoietic stem cells.

Authors:  E S Golub
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  25 in total

1.  Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.

Authors:  Z Fuks; S Strober; A M Bobrove; T Sasazuki; A McMichael; H S Kaplan
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

2.  Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer.

Authors:  Jian L Campian; Guneet Sarai; Xiaobu Ye; Shanthi Marur; Stuart A Grossman
Journal:  Head Neck       Date:  2014-04-15       Impact factor: 3.147

3.  Immune function of successfully treated lymphoma patients.

Authors:  G W King; B Yanes; P E Hurtubise; S P Balcerzak; A F LoBuglio
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

4.  T- and B-lymphocyte subpopulations following radiotherapy for invasive squamous cell carcinoma of the uterine cervix.

Authors:  R J Rand; D M Jenkins; R Bulmer
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

5.  Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer.

Authors:  S Yoshida; M Matsui; Y Shirouzu; H Fujita; H Yamana; K Shirouzu
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

6.  Lymphopenia during radiotherapy in patients with oropharyngeal cancer.

Authors:  Sweet Ping Ng; Houda Bahig; Amit Jethanandani; Courtney Pollard; Joel Berends; Erich M Sturgis; Faye M Johnson; Baher Elgohari; Hesham Elhalawani; David I Rosenthal; Heath D Skinner; G Brandon Gunn; Jack Phan; Steven J Frank; Abdallah S R Mohamed; Clifton D Fuller; Adam S Garden
Journal:  Radiother Oncol       Date:  2020-01-10       Impact factor: 6.280

7.  A novel deep learning model using dosimetric and clinical information for grade 4 radiotherapy-induced lymphopenia prediction.

Authors:  Cong Zhu; Steven H Lin; Xiaoqian Jiang; Yang Xiang; Zayne Belal; Goo Jun; Radhe Mohan
Journal:  Phys Med Biol       Date:  2020-02-04       Impact factor: 3.609

8.  Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer.

Authors:  Joji Kitayama; Koji Yasuda; Kazushige Kawai; Eiji Sunami; Hirokazu Nagawa
Journal:  Radiat Oncol       Date:  2010-06-03       Impact factor: 3.481

9.  Antibody-dependent cellular cytotoxicity-mediated serotherapy against murine neuroblastoma. II. In vitro and in vivo treatment using effector cells from normal and X-irradiated humans.

Authors:  J E Byfield; R Zerubavel; E W Fonkalsrud
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Abrogation of the tumor promoting effect of allogeneic blood transfusion by polyadenylic-polyuridylic acid (poly A-poly U).

Authors:  S K Singh; R L Marquet; D L Westbroek; J Jeekel
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.